M&A

News

23andMe's co-founder and former chief executive, Anne Wojcicki, looks set to regain control of the genetic testing business.

News

BioNTech has agreed to buy another specialist in mRNA medicines, fellow German biotech CureVac, for around $1.25 billion.

News

A new auction for bankrupt genetic testing company 23andMe looks likely after former CEO Anne Wojcicki offered to outbid Regeneron.

News

Faced with the looming loss of patent protection for Keytruda, MSD is reported to be interested in buying Swiss immunology player MoonLake.

News

US telehealth company Hims & Hers has reached a deal to buy its UK counterpart Zava as part of a broader push into Europe.

News

Beckley Psytech has agreed to merge with atai Life Sciences in a deal that would bring together two psychedelic medicine pioneers.